Silicon Laboratories Stock (NASDAQ: SLAB)

Dernières nouvelles pour Silicon Laboratories (NASDAQ:SLAB) Stock

SILICON LABORATORIES INC

Silicon Laboratories

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

Silicon Laboratories, Inc. - Common Stock

Silicon Laboratories Inc

News

SLAB

Silicon Labs And Wirepas Achieve 10M Chip Milestone, Enabling India's Smart Grid And Global Industrial IoT At Scale

Benchmark analyst Cody Acree reiterates Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Buy and maintains $160 price target.

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Silicon Laboratories, Maintains $160 Price Target

Silicon Labs Unveils SiXG301 And SiXG302 SoCs To Power High-Performance, Energy-Efficient IoT Applications

Silicon Laboratories, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading relatively flat on Wednesday.</a>
On Tuesday, the company reported first-quarter results, with revenues of $178 million, beating the Street View. Industrial &amp; Commercial revenue for the quarter was $96 million, up 47% year-over-year, while Home &amp; Life revenue for the quarter was $82 million, up 99%.
Here are the key analysts&#8217;<a target="_blank" href="https://www.benzinga.com/quote/SLAB/analyst-ratings" rel="noreferrer noopener"> takeaways from the earnings:</a>
<ul class="wp-block-list">
<li>Benchmark analyst Cody Acree reiterated the Buy rating on the stock, with a price forecast of $160.</li>
<li>Needham analyst N. Quinn Bolton reiterated the Buy rating on Silicon Laboratories, with a price forecast of $150.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45406180/only-half-of-sp-500-stocks-joined-the-tariff-relief-rally-time-to-buy-the-laggards" rel="noreferrer noopener">Only Half Of S&amp;P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?</a>
Benchmark: Acree notes that Silicon Labs (SLAB) experienced a quarter-over-quarter improvement in customer bookings and distribution point-of-sale trends during the first quarter, with this positive momentum continuing into the second quarter.
This suggests that both customer and channel inventory levels have returned to more typical levels. The company&#8217;s end markets are also gradually recovering from their cyclical downturn.
Silicon Labs reaffirmed its confidence in the full-year outlook shared at its March 11 analyst day. The company remains on track to meet the FY25 Street revenue estimate of $785 million.
Acree anticipates modest upward revisions to consensus following the latest positive results and guidance. T
To reach his updated FY25 forecast of $789.2 million, Acree projects the firm to deliver mid-single-digit quarter-over-quarter growth in the third and fourth quarters, translating to $203 million and $216 million in sales, respectively—figures that closely align with current market expectations.
Needham: Bolton notes that management has reaffirmed its expectation of more than 20% year-over-year revenue growth for FY25, while he projects a higher 33% increase, citing minimal impact from tariffs.
Gross margins are performing better than anticipated, driven by a favorable product mix and stable pricing. As a result, the company revised margin forecasts slightly upward.
Bolton projects second-half growth to be supported by the ramp-up of design wins in areas such as smart metering, continuous glucose monitors (CGMs), and electronic shelf labels (ESLs).
The analyst also observes that inventory levels are being well managed, with only moderate sequential increases expected through the first quarter of FY26.
Price Action: Silicon Laboratories shares are trading lower by 0.93% to $132.46 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45399438/smci-rated-outperform-by-raymond-james-amid-dominance-in-branded-ai-server-market" target="_blank" rel="noreferrer noopener">SMCI Stock In ‘Sweet Spot,' Says Raymond James — Sets $41 Price Target As AI Revenue Hits 70%</a></li>
</ul>
Image: Shutterstock

Equities

Markets

Trading Ideas

General

Silicon Labs Revenue Beats Estimates, Analysts Highlight Inventory Recovery

Susquehanna analyst Christopher Rolland maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Neutral and raises the price target from $100 to $110.

Susquehanna Maintains Neutral on Silicon Laboratories, Raises Price Target to $110

Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $136.67, a high estimate of $160.00, and a low estimate of $80.00. Experiencing a 7.34% decline, the current average is now lower than the previous average price target of $147.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1747224095_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Silicon Laboratories. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cody Acree</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Cody Acree</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Silicon Laboratories. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Silicon Laboratories compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Silicon Laboratories's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Silicon Laboratories's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SLAB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Silicon Laboratories analyst ratings.</a>
<h2>About Silicon Laboratories</h2>
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
<h3>Silicon Laboratories: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Silicon Laboratories's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 91.43%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -14.33%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Silicon Laboratories's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -2.2%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Silicon Laboratories's ROA excels beyond industry benchmarks, reaching -1.93%. This signifies efficient management of assets and strong financial health.
Debt Management: Silicon Laboratories's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Silicon Laboratories In The Eyes Of 6 Experts

Needham analyst Quinn Bolton reiterates Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Buy and maintains $150 price target.

Needham Reiterates Buy on Silicon Laboratories, Maintains $150 Price Target

WIIM

AAOI

AIRG

ALAB

ALGM

ALLT

AMBR

ANET

AVPT

BBAI

CRDO

CRWD

DELL

DOCU

FTNT

FUFU

KVYO

LDTC

MOVE

MPWR

NTNX

ORCL

PLTR

PMTS

PSTG

RBRK

SKYT

TEAM

TSSI

TWLO

WOLF

XTKG

Shares of companies within the broader tech sector are trading higher amid overall market strength following softer-than-expected April inflation readings. Additionally, investors continue to weigh US-China trade progress and President Trump's Middle East trip.

Guidance

Silicon Laboratories Sees Q2 Adj EPS $(0.01)-$0.19 vs $(0.09) Est; Sees Sales $185.000M-$200.000M vs $177.49M Est

Earnings

Earnings Beats

Silicon Laboratories Q1 Adj. EPS $(0.08) Beats $(0.09) Estimate, Sales $178.00M Beat $177.47M Estimate

ABOS

ABSI

ACCS

ACHV

ACXP

ADAP

ALCO

ALLO

ASNS

AUID

AVXL

BDSX

BEAT

BKTI

BWAY

BWEN

CAMT

CAPR

CINT

CLPT

CLRB

CNCK

CYBR

DARE

DLPN

DMAC

ELMD

ETON

EXEL

FENC

FLOC

FTHM

GAIN

GAUZ

GENK

GEVO

GNSS

GOCO

GRAL

GUTS

HSON

HUMA

HUYA

HYFM

HYLN

HYPR

ICMB

IMOS

INLX

IRIX

ITRM

IZEA

KOPN

KRMN

LCTX

LEGN

LOAR

LSTR

LUNR

LXRX

MASS

MBRX

MCHX

MDAI

MGNX

MPTI

NMTC

NPCE

NUTX

NUWE

NXGL

NYAX

OKLO

ONON

OPXS

PERI

PRTS

PSFE

PXLW

Earnings Scheduled For May 13, 2025

ACLS

ACMR

AMBA

AMKR

AOSL

ATOM

AXTI

BZAI

CEVA

CRUS

CSIQ

DIOD

ENTG

FORM

FSLR

GCTS

HIMX

ICHR

INDI

KLIC

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MKSI

MOBX

MTSI

NVMI

NVTS

OLED

Penguin Solutions, Inc. - Ordinary Shares

PENG

POWI

QRVO

RGTI

SITM

SMTC

SWKS

SYNA

UCTT

VECO

Shares of semiconductor companies are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

AMAT

AVGO

COHU

INTC

KLAC

LSCC

MCHP

MRVL

NVDA

NXPI

ONTO

QCOM

RMBS

SMCI

Shares of semiconductor companies are trading higher amid overall market strength due to March's strong durable goods orders economic data, and President Trump's announcement that he met with China earlier today.

Comments

Silicon Laboratories

Actualités

Dernières nouvelles pour Silicon Laboratories (NASDAQ:SLAB) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL